Xbrane Biopharma

Major Shareholding Notification • Sep 14, 2023

Issuer Xbrane Biopharma AB

Holder

Swedbank Robur Fonder AB

Instrument

Instrument	Aktier SE0007789409
Before the transaction
Shares	1,461,892
Voting rights	1,461,892
Transaction
Reason for major shareholding notification Sell
Date	13/09/2023
Limit for number of shares	5 %
Limit for number of votes	5 %
After the transaction
Quantity
Shares	1,441,892
Directly held voting rights	1,441,892
Indirectly held voting rights	0
Percentage
Directly held shares	4.94 %
Directly held voting rights	4.94 %
Indirectly held voting rights	0 %

Resulting distribution of total holdings

	Percentage of voting rights:	Number of underlying shares:
Shares	4.94 %	1,441,892
Instruments - FITA Ch. 4, section 2, first paragraph, line 2
Instruments - FITA Ch. 4, section 2, first paragraph, line 3
- Physically settled
- Cash settled
Total	4.94 %	1,441,892
Published
14/09/2023 11:26
Contact
Name Mats Frankeus
Phone 08-58592400 Email mats.frankeus@swedbankrobur.se

CLOSE PRINT

rapportering@fi.se Tfn 08-408 980 37 Fax 08-24 39 25